Gossamer Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Gossamer Bio and other ETFs, options, and stocks.

About GOSS

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. 

CEO
Faheem Hasnain
CEOFaheem Hasnain
Employees
162
Employees162
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2015
Founded2015
Employees
162
Employees162

GOSS Key Statistics

Market cap
86.97M
Market cap86.97M
Price-Earnings ratio
-0.25
Price-Earnings ratio-0.25
Dividend yield
Dividend yield
Average volume
32.60M
Average volume32.60M
High today
$0.207
High today$0.207
Low today
$0.17
Low today$0.17
Open price
$0.1991
Open price$0.1991
Volume
29.15M
Volume29.15M
52 Week high
$3.87
52 Week high$3.87
52 Week low
$0.1138
52 Week low$0.1138

Stock Snapshot

As of today, Gossamer Bio(GOSS) shares are valued at $0.18. The company's market cap stands at 86.97M, with a P/E ratio of -0.25.

On 2026-08-26, Gossamer Bio(GOSS) stock traded between a low of $0.17 and a high of $0.21. Shares are currently priced at $0.18, which is +5.3% above the low and -13.5% below the high.

The Gossamer Bio(GOSS)'s current trading volume is 29.15M, compared to an average daily volume of 32.6M.

In the last year, Gossamer Bio(GOSS) shares hit a 52-week high of $3.87 and a 52-week low of $0.11.

In the last year, Gossamer Bio(GOSS) shares hit a 52-week high of $3.87 and a 52-week low of $0.11.

GOSS News

Benzinga 5d
Gossamer Bio Slips as $250M Financing Hinges on FDA Approval - Gossamer Bio - Benzinga

...

Gossamer Bio Slips as $250M Financing Hinges on FDA Approval - Gossamer Bio - Benzinga
TipRanks 6d
Gossamer Bio announces upt to $250M structured private placement

Gossamer Bio (GOSS) entered into a securities purchase agreement with certain new and existing institutional investors for a private placement financing expecte...

Analyst ratings

43%

of 7 ratings
Buy
42.9%
Hold
42.9%
Sell
14.3%

People also own

Based on the portfolios of people who own GOSS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.